Radiopharm Theranostics Limited (ASX:RAD – Get Free Report) insider Paul Hopper sold 1,500,000 shares of the business’s stock in a transaction that occurred on Thursday, December 5th. The shares were sold at an average price of A$0.03 ($0.02), for a total value of A$43,500.00 ($27,707.01).
Radiopharm Theranostics Price Performance
Radiopharm Theranostics Company Profile
Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It is developing its lead products comprising Nano-mAbs and AVB6 Integrin. The company was incorporated in 2021 and is based in Carlton, Australia.
Read More
- Five stocks we like better than Radiopharm Theranostics
- Golden Cross Stocks: Pattern, Examples and Charts
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Radiopharm Theranostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Radiopharm Theranostics and related companies with MarketBeat.com's FREE daily email newsletter.
